STM Journals Peer-reviewed research from Consortium e-Learning Network

Research & Reviews: A Journal of Bioinformatics Original Research

The Utilization of Oil Entrapped Floating Alginate Beads in a Gastroretentive Delivery System is Intended to Improve the Bioavailbility of Telmisartan Incorporating Principles of Bioinformatics

  1. Gouthami Polaki
  2. Nansri Saha

Abstract

Oil entrapped floating calcium alginate beads of Telmisartan were successfully prepared using sodium alginate as polymer and two different oil phases of mineral oil and olive oil by emulsion gelation method. The FT-IR spectra of final optimized formulation confirms no drug- polymer incompatibility. The floating time of beads was found to be more than 12 hrs suggesting that the method used for prepration was effective. The floating time of optimized formulation was within 6 minutes and floating time significantly increased as the amount of oil was increased in each formulation. The mean particle size of beads was in range from (1.204 mm to 2.0072 mm) depending upon the type of polymer used. The particle size increased significantly as the amount of polymer was increased in each preparation. The %Entrapment efficiency of beads ranging from41.14%–85.79% increased in concentration of polymer leads to increase in entrapment efficiency. The best formulation of oil entrapped floating calcium alginate beads of Telmisartan for mineral oil was found to be F5 98.03% and for Olive oil oil was found to be F7 96.7%, drug release in 12 hrs. The release kinetics of the optimized Telmisartan loaded oil entrapped beads showed that it follows Higuchi release kinetics. The release of the drug from the dosage form is carried out by diffusion and follows Korsmeyer peppas kinetics and the n value is greater than 0.5 indicating non-Fickian release. The floating beads have been employed to make a sustained release of the drug in the stomach to enhance bioavailability and to decrease dose dumping and hence overcome its side effects. The developed formulation shows an alternative to the conventional dosage form for the treatment of Telmisartan, a nonsedating antihistamine H1 blocker used for seasonal allergic rhinitis and chronic idiopathic urticaria has limited absorption in the upper small intestine with poor oral bioavailability. Hence finally it was concluded that the prepared oil entrapped floating sodium alginate beads of Telmisartan may prove to be potential candidate for safe and effective sustained drug delivery over an extended period of time which can reduce dosing frequency and improved oral bioavailability.

Keywords

References (42)

  1. Mudie DM, Amidon GL, Amidon GE. Physiological parameters for oral delivery and in vitro
  2. testing. Mol Pharm 2010;7:1388–1405.
  3. Nayak AK, Malakar J, Sen KK. Gastroretentive drug delivery technologies: current approaches and
  4. future potential. J Pharm Educ Res 2010;1:1–12.
  5. Sugihara H, Matsui Y, Takeuchi H, et al. Development of a gastric retentive system as a sustained-
  6. release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies.
  7. Eur J Pharm Sci 2014;53:62–68.
  8. Thakar K, Joshi G, Sawant KK. Bioavailability enhancement of baclofen by gastroretentive floating
  9. formulation: statistical optimization, in vitro and in vivo pharmacokinetic studies. Drug Dev Ind
  10. Pharm 2013;39:880–888.
  11. Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug-delivery systems. Expert Opin
  12. Drug Deliv 2011;8:1189– 1203.
  13. Kesarla RS, Vora PA, Sridhar BK, et al. Formulation and evaluation of floating tablet of H2-
  14. receptor antagonist. Drug Dev Ind Pharm 2015;41:1499–1511.
  15. Kumar R, Philip A. Gastroretentive dosage forms for prolonging gastric residence time. Int J Pharm
  16. Med 2007;21:157–171.
  17. Aoki H, Iwao Y, Mizoguchi M, et al. Clarithromycin highlyloaded gastro-floating fine granules
  18. prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori
  19. eradication. Eur J Pharm Biopharm 2015;92:22–27.
  20. Adebisi AO, Laity PR, Conway BR. Formulation and evaluation of floating mucoadhesive alginate
  21. beads for targeting Helicobacter pylori. J Pharm Pharmacol 2015;67:511– 524.
  22. Kim JY, Bae HJ, Choi J, et al. Efficacy of gastro-retentive forms of ecabet sodium in the treatment
  23. of gastric ulcer in rats. Arch Pharm Res 2014;37:1053–1062.
  24. Li SL, Tu XD, Mao FF. Development and pharmacokinetic study of metoprolol tartrate controlled-
  25. release tablet remaining-floating in stomach. Yao Xue Xue Bao 1989;24:381–386.
  26. Kaushik AY, Tiwari AK, Gaur A. Role of excipients and polymeric advancements in preparation
  27. of floating drug delivery systems. Int J Pharm Investig 2015;5:1–12.
  28. Ishak RA. Buoyancy-generating agents for stomach-specific drug delivery: an overview with
  29. special emphasis on floating behavior. J Pharm Pharm Sci 2015;18:77–100.
  30. Malik R, Garg T, Goyal AK, et al. Polymeric nanofibers: targeted gastro-retentive drug delivery
  31. systems. J Drug Target 2015;23:109–124.
  32. Gopalakrishnan S, Chenthilnathan A. Floating drug delivery systems: a review. J Pharm Sci
  33. Technol 2011;3:548–554.
  34. Shahaa SH, Patelb JK, Pundarikakshudua K, et al. An overview of a gastro-retentive floating drug
  35. delivery system. Asian J Pharm Sci 2009;4:65–80.
  36. Gutierrez-Rocca J, Omidian H, Shah K. Progresses in gastroretentive drug delivery systems. Bus
  37. Brief Pharmatech 2003;15:3–6.
  38. Klausner EA, Lavy E, Friedman M, et al. Expandable gastroretentive dosage forms. J Control
  39. Release 2003;90:143– 162.
  40. Pawar VK, Kansal S, Asthana S, et al. Industrial perspective of gastroretentive drug delivery
  41. systems: physicochemical, biopharmaceutical, technological and regulatory consideration. Expert
  42. Opin Drug Deliv 2012;9:551–565.
Support